Li Jing Jing, Dolios Georgia, Wang Rong, Liao Francesca-Fang
Department of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America.
Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York, United States of America.
PLoS One. 2014 Mar 4;9(3):e90770. doi: 10.1371/journal.pone.0090770. eCollection 2014.
Recent studies indicate that soluble β-amyloid (sAβ) oligomers, rather than their fibrillar aggregates, contribute to the pathogenesis of Alzheimer's disease (AD), though the mechanisms of their neurotoxicity are still elusive. Here, we demonstrate that sAβ derived from 7PA2 cells exert a much stronger effect on the regulation of a set of functionally validated microRNAs (miRNAs) in primary cultured neurons than the synthetic insoluble Aβ fibrils (fAβ). Synthetic sAβ peptides at a higher concentration present comparable effect on these miRNAs in our neuronal model. Further, the sAβ-induced miR-134, miR-145 and miR-210 expressions are fully reversed by two selective N-methyl-d-aspartate (NMDA) receptor inhibitors, but are neither reversed by insulin nor by forskolin, suggesting an NMDA receptor-dependent, rather than PI3K/AKT or PKA/CREB signaling dependent regulatory mechanism. In addition, the repression of miR-107 expression by the sAβ containing 7PA2 CM is likely involved multiple mechanisms and multiple players including NMDA receptor, N-terminally truncated Aβ and reactive oxygen species (ROS).
最近的研究表明,可溶性β-淀粉样蛋白(sAβ)寡聚体而非其纤维状聚集体,在阿尔茨海默病(AD)的发病机制中起作用,尽管其神经毒性机制仍不清楚。在此,我们证明,源自7PA2细胞的sAβ对原代培养神经元中一组功能已得到验证的微小RNA(miRNA)的调控作用,比合成的不溶性Aβ纤维(fAβ)更强。在我们的神经元模型中,较高浓度的合成sAβ肽对这些miRNA具有类似的作用。此外,两种选择性N-甲基-D-天冬氨酸(NMDA)受体抑制剂可完全逆转sAβ诱导的miR-134、miR-145和miR-210的表达,但胰岛素或福斯高林不能逆转,这表明其调控机制依赖于NMDA受体,而非PI3K/AKT或PKA/CREB信号通路。此外,含有7PA2条件培养基的sAβ对miR-107表达的抑制可能涉及多种机制和多个因素,包括NMDA受体、N端截短的Aβ和活性氧(ROS)。